Absci accelerates ABS-201 in alopecia & endometriosis, targets data by 2027, and refocuses pipeline for value.

NEW YORK, NY / ACCESS Newswire / November 5, 2025 / There’s a moment in every company’s life when the work stops feeling ...

Damora Therapeutics, the sixth company launched based on assets developed by Paragon Therapeutics, is advancing a portfolio of anti-mutant calreticulin (mutCALR) targeted therapies, led by DMR-001, a ...

NEW YORK, NY / ACCESS Newswire / November 5, 2025 / Every generation reaches a point when progress demands proof. For Europe, following Singapore’s unprecedented action to usher in circularity, that ...

The story depicted on the ˁAin Samiya goblet—an 8 cm tall silver vessel from the Intermediate Bronze Age (c. 2650–1950 ...

Beck's first draft was initially rejected by Underground bosses. His final version was published on January 1, 1933, and was” ...

Ken Burns' latest opus is solid storytelling. It also highlights the costliness of our ignorance about our history.

There comes a point in every company's journey when innovation stops being an idea and becomes infrastructure. SMX ...

For young professionals, the lure of direct stocks, instant control, multi-bagger dreams, and social-media bravado is ...

India’s startup-to-IPO journey represents the maturity of its capital market from funding promises to funding proof ...

In his second novel, Canary, Dr Onke Mazibuko writes about whistleblowing, corporate bullying and mental health ...